Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 7, 2017; 23(21): 3915-3927
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3915
Published online Jun 7, 2017. doi: 10.3748/wjg.v23.i21.3915
Rome IV nomenclature1 | Frequency | Duration | Synonym, subtypes or approximate terms | |
H1: Functional nausea and vomiting disorders | ||||
H1a. | Cyclic vomiting syndrome | ≥ 2 periods of intense, unremitting nausea and paroxysmal vomiting | h-d/6 mo | Periodic vomiting |
H1b1. | Functional nausea | ≥ 2 nausea episodes/wk | ≥ 2 mo | Bothersome nausea |
H1b2. | Functional vomiting | ≥ 1 vomiting episode/wk | ≥ 2 mo | - |
H1c. | Rumination syndrome | Repetitive regurgitation and rechewing or expulsion of food | ≥ 2 mo | Adolescent rumination syndrome2; regurgitation, reswallowing, spitting |
H1d. | Aerophagia | Repetitive belching and/or increased flatus | ≥ 2 mo | - |
H2: Functional abdominal pain disorders | ||||
H2a. | Functional dyspepsia | ≥ 1 symptom for ≥ 4 d/mo | ≥ 2 mo | Postprandial distress syndrome; |
Epigastric pain syndrome | ||||
H2b. | Irritable bowel syndrome | Abdominal pain for ≥ 4 d/mo | ≥ 2 mo | Abdominal discomfort2; |
Manning criteria | ||||
H2c. | Abdominal migraine | ≥ 2 intense abdominal pain episodes | ≥ 1 h/6 mo | Periumbilical pain2 |
H2d. | Functional abdominal pain - not otherwise specified | ≥ 4 episodic or continuous abdominal pain/mo | ≥ 2 mo | Functional abdominal pain2; |
Functional abdominal pain syndrome2 | ||||
H3: Functional defecations disorders | ||||
H3a. | Functional constipation | ≤ 2 defecations/wk | ≥ 1 mo | - |
≥ 1 fecal incontinence/wk | ||||
H3b. | Nonretentive fecal incontinence | Episodes of fecal loss | ≥ 1 mo | - |
Author, year, country | Study design, setting | Sample size (participation %) | Age bracket yr | Case definition | Case ascertainment | Score1 | FGID subtype prevalence % (CI 95%) | ||
Cyclic vomiting | Aerophagia | Rumination | |||||||
Bhatia et al[6], 2016, India | Cross-sectional, school-based | 1200 (93.3) | 10-17 | Rome III | Self-reported QPGS-RIII | 5 | 0.2 | 1.5 | 0.3 |
Medical records | |||||||||
Physical examination | |||||||||
Caplan et al[18], 2005, Canada | Cross-sectional, tertiary care | 315 (NR) | 4-18 | Rome II | Self-reported QPGS | 3 | p 4-9 yr = 6.2 | p 4-9 yr = 1.1 | |
Parental QPGS | p 10-18 yr = 2.2 | p 10-18 yr = 2.2 | |||||||
Clinical evaluation | a 10-18 yr = 4.3 | a 10-18 yr = 1.4 | |||||||
Devanarayana et al[36], 2010, Sri Lanka | Cross-sectional, school-based | 464 (92) | 12-16 | Rome II | Self-reported QPGS | 4 | 0.2 | 6.1 | |
Rome III | 0.5 | 6.3 | 4.0 | ||||||
Helgeland et al[35], 2009, Norway | Cross-sectional, secondary care | 192 (79.1) | 4-15 | Rome III | Parental QPGS-III | 3 | 6.0 | 15.0 | 2.0 |
Clinical evaluation | |||||||||
Medical records | |||||||||
Physical examination | |||||||||
Laboratory exams | |||||||||
Játiva et al[30], 2016, Ecuador | Cross-sectional, school-based | 420 (99.3) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 1.0 | 2.6 | 0.7 |
Parental standard questionnaire | |||||||||
Lewis et al[25], 2016, United States | Cross-sectional, online panel community | 1447 (NR) | 4-18 | Rome III | Parental QPGS-RIII | 2 | 1.1 | 4.3 | 0.0 |
PedsQL4.0 | |||||||||
Lu et al[28], 2016, Panama | Cross-sectional, school-based | 436 (82.8) | 8-14 | Rome III | Self-reported QPGS-RIII | 4 | 0.3 (0.0-0.9) | 0.3 (0.0-0.9) | 0.0 |
Parental standard questionnaire | |||||||||
Sagawa et al[16], 2012, Japan | Cross-sectional, school-based | 3976 (NR) | 10-17 | Rome III | Self-reported QPGS-RIII | 6 | 0.2 | 2.0 | 0.1 |
Self-reported PedsQL4.0 | |||||||||
Clinical evaluation | |||||||||
Saps et al[26], 2014, Colombia | Cross-sectional, school-based | 488 (83.2) | 10.0 (mean age) | Rome III | Self-reported QPGS-RIII | 4 | 0.3 (0.0-1.7) | ||
Parental standard questionnaire | |||||||||
Uc et al[22], 2006, United States | Cross-sectional, primary care | 243 (100) | 4-17 | Rome II | Parental QPGS | 4 | 0.8 | 2.5 | |
Clinical evaluation | |||||||||
van Tilburg et al[24], 2013, United States | Cross-sectional, tertiary care | 135 (NR) | 4-18 | Rome III | Self-reported QPGS-III | 3 | p = 0.8 | p = 0.8 | p = 0.8 |
Parental QPGS-III | c/a = 5.3 | c/a = 3.5 | c/a = 5.3 | ||||||
Clinical evaluation | ph = 0 | ph = 0 | ph = 0 | ||||||
Medical records | |||||||||
Zablah et al[27], 2015, El Salvador | Cross-sectional, school-based | 434 (NR) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 0.5 | 0.2 | |
Parental standard questionnaire |
Author, year, country | Study design, setting | Sample size (participation %) | Age bracket yr | Case definition | Case ascertainment | Score1 | FGID subtype prevalence %( 95%CI) | |||
Dyspepsia | Irritable bowel | Abdominal migraine | Abdominal pain - NOS | |||||||
Baber et al[8], 2008, United States | Cross-sectional, tertiary care | 548 (80.1) | 8-17 | Rome II | Parental QPGS | 5 | 19.6 | 44.0 | 5.7 | 2.7 |
Rome III | Clinical evaluation | 15.2 | 45.1 | 23.1 | 17.4 | |||||
Medical records | ||||||||||
Laboratory exams | ||||||||||
Bhatia et al[6], 2016, India | Cross-sectional, school-based | 1200 (93.3) | 10-17 | Rome III | Self-reported QPGS-RIII | 5 | 2.7 | 1.3 | 1.4 | 0.8 |
Medical records | ||||||||||
Physical examination | ||||||||||
Caplan et al[18], 2005, Canada | Cross-sectional, tertiary care | 315 (NR) | 4-18 | Rome II | Self-reported QPGS | 3 | p 4-9 yr = 13.5 | p 4-9 yr = 22.0 | p 4-9 yr = 0 | p 4-9 yr = 0 |
Parental QPGS | p 10-18 yr = 14.4 | p 10-18 yr = 23.9 | p 10-18 yr = 0.7 | p 10-18 yr = 2.9 | ||||||
Clinical evaluation | a 10-18 yr = 10.2 | a 10-18 yr = 35.5 | a 10-18 yr = 2.2 | a 10-18 yr = 2.9 | ||||||
Cristofori et al[33], 2014, Italy | Cross-sectional, tertiary care | 992 (NR) | 4-16 | Rome III | Clinical evaluation | 4 | 25.7 | 34.5 | 0.0 | 39.8 |
Medical records | ||||||||||
Laboratory exams | ||||||||||
Devanarayana et al[36], 2010, Sri Lanka | Cross-sectional, school-based | 464 (92) | 12-16 | Rome II | Self-reported QPGS | 4 | 1.2 | 2.8 | 0.2 | 1.4 |
Rome III | 3.5 | 7.0 | 0.2 | 3.0 | ||||||
Dong et al[37], 2005, China | Cross-sectional, school-based | 5403 (NR) | 6-18 | Rome II | Self-reported standard questionnaire | 6 | 13.2 | |||
Parental standard questionnaire | ||||||||||
Medical records | ||||||||||
Gijsbers et al[32], 2014, the Netherlands | Cross-sectional, secondary care | 220 (NR) | 4-16 | Rome III | Clinical evaluation | 3 | 3.6 | 5.0 | 0.0 | 15.0 |
Medical records | ||||||||||
Laboratory exams | ||||||||||
Gulewitsch et al[34], 2013, Germany | Cross-sectional, school-based | 3658 (43.1) | 5-12 | Rome III | Parental QPGS-RIII | 2 | 0.2 | 4.9 | 1.0 | 3.6 |
Parental CSI | ||||||||||
Parental SDQ | ||||||||||
Helgeland et al[35], 2009, Norway | Cross-sectional, secondary care | 192 (NR) | 4-15 | Rome III | Parental QPGS-III | 3 | 10.0 | 43.0 | 23.0 | 15.0 |
Clinical evaluation | ||||||||||
Medical records | ||||||||||
Physical examination | ||||||||||
Laboratory exams | ||||||||||
Játiva et al[30], 2016, Ecuador | Cross-sectional, school-based | 420 (99.3) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 0.5 | 4.8 | 2.4 | 3.1 |
Parental standard questionnaire | ||||||||||
Lewis et al[25], 2016, United States | Cross-sectional, online painel community | 1447 (NR) | 4-18 | Rome III | Parental QPGS-RIII | 2 | 0.2 | 2.8 | 9.2 | 11.6 |
PedsQL4.0 | ||||||||||
Lu et al[29], 2016, Colombia | Cross-sectional, school-based | 4751 (89.8) | 8-18 | Rome III | Self-reported QPGS-RIII | 3 | 4.8 | |||
Parental standard questionnaire | ||||||||||
Lu et al[28], 2016, Panama | Cross-sectional, school-based | 436 (82.8) | 8-14 | Rome III | Self-reported QPGS-RIII | 4 | 0.9 (0.0-2.0) | 5.6 (3.1-8.1) | 1.7 (0.2-2.9) | 3.7 (1.7-5.8) |
Parental standard questionnaire | 0.3 (0.0-0.9) | |||||||||
Sagawa et al[16], 2012, Japan | Cross-sectional, school-based | 3976 (NR) | 10-17 | Rome III | Self-reported QPGS-RIII | 6 | 0.9 | 5.9 | 1.8 | 4.2 |
Self-reported PedsQL4.0 | ||||||||||
Clinical evaluation | ||||||||||
Saps et al[23], 2012, United States | Cross-sectional, Community | 984 (25) | 4-18 | Rome III | Parental QPGS-III | 2 | 8.1 | |||
Saps et al[26], 2014, Colombia | Cross-sectional, school-based | 488 (83.2) | 10.0 (mean age) | Rome III | Self-reported QPGS-RIII | 4 | 1.7 (0.8-3.9) | 5.4 (3.9-8.8) | 1.0 (0.3-2.8) | 2.7 (1.6-5.2) |
Parental standard questionnaire | 0.3 (0.0-1.7) | |||||||||
Schurman et al[21], 2005, United States | Cross-sectional, tertiary care | 205 (75) | 8-18 | Rome II | Self-reported QPGS | 3 | p = 47 | p = 20; | p < 10 | p < 10 |
Parental QPGS | c/a = 35 | c/a = 30; | c/a < 10; | c/a < 10 | ||||||
Clinical evaluation | ph = 57 | ph = 12 | ph < 10 | ph < 10 | ||||||
Uc et al[22], 2006, United States | Cross-sectional, primary care | 243 (100) | 4-17 | Rome II | Parental QPGS | 4 | 0.8 | 0.0 | 0.4 | 0.4 |
Clinical evaluation | ||||||||||
Udoh et al[41], 2016, Nigeria | Cross-sectional, school-based | 856 (NR) | 10-18 | Rome III | Self-reported QPGS-RIII | 4 | 0.4 | 5.6 | 1.8 | 2.6 |
Standard questionnaires | ||||||||||
Walker et al[20], 2004, United States | Cross-sectional, tertiary care | 114 (NR) | 4-17 | Rome II | Parental QPGS | 3 | 15.9 | 44.9 | 4.7 | 7.5 |
Clinical evaluation | ||||||||||
Parental standard interview | ||||||||||
Medical records | ||||||||||
Physical examination | ||||||||||
Laboratory exams | ||||||||||
Yamamoto et al[40], 2015, Japan | Cross-sectional, school-based | 99416 (92.2) | 12-18 | Rome III | Self-reported standard questionnaire | 6 | 18.6 (17.9-19.2) | |||
Zablah et al[27], 2015, El Salvador | Cross-sectional, school-based | 434 (NR) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 1.7 | 3.7 | 0.7 | 3.0 |
Parental standard questionnaire | ||||||||||
Zhou et al[38], 2011, China | Cross-sectional, school-based | 3671 (NR) | 12-18 | Rome III | Self-reported standard questionnaire | 5 | 19.8 (18.6-21.1) |
Author, year, country | Study design, setting | Sample size (participation %) | Age bracket yr | Case definition | Case ascertainment | Score1 | FGID subtype prevalence % (95%CI) | |
Constipation | Nonretentive fecal incontinence | |||||||
Bhatia et al[6], 2016, India | Cross-sectional, school-based | 1200 (93.3) | 10-17 | Rome III | Self-reported QPGS-RIII | 5 | 0.5 | 0.4 |
Medical records | ||||||||
Physical examination | ||||||||
Burgers et al[31], 2012, Netherlands | Cross-sectional (retrospective), tertiary care | 176 (NR) | 6-18 | Rome II | Clinical evaluation | 3 | 5.7 | |
Rome III | Medical records | 86.9 | ||||||
Physical examination | ||||||||
Caplan et al[18], 2005, Canada | Cross-sectional, tertiary care | 315 (NR) | 4-18 | Rome II | Self-reported QPGS | 3 | p 4-9 yr = 19.2 | p 4-9 yr = 0.6 |
Parental QPGS | p 10-18 yr = 13.8 | p 10-18 yr = 0.7 | ||||||
Clinical evaluation | c/a 10-18 yr = 15.2 | c/a 10-18 yr = 0.7 | ||||||
Devanarayana et al[36], 2010, Sri Lanka | Cross-sectional, school-based | 464 (92) | 12-16 | Rome II | Self-reported QPGS | 4 | 1.4 | 0.2 |
Rome III | 4.2 | 0.2 | ||||||
Helgeland et al[35], 2009, Norway | Cross-sectional, tertiary care | 192 (NR) | 4-15 | Rome III | Parental QPGS-III | 3 | 6.0 | |
Clinical evaluation | ||||||||
Medical records | ||||||||
Physical examination | ||||||||
Laboratory exams | ||||||||
Játiva et al[30], 2016, Ecuador | Cross-sectional, school-based | 420 (99.3) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 11.8 | 0.2 |
Parental standard questionnaire | ||||||||
Lewis et al[25], 2016, United States | Cross-sectional, online painel community | 1447 (NR) | 4-18 | Rome III | Parental QPGS-RIII | 2 | 12.9 | 1.8 |
PedsQL4.0 | ||||||||
Lu et al[29], 2016, Colombia | Cross-sectional, school-based | 4751 (89.8) | 8-18 | Rome III | Self-reported QPGS-RIII | 3 | 12.7 | |
Parental standard questionnaire | ||||||||
Lu et al[28], 2016, Panama | Cross-sectional, school-based | 436 (82.8) | 8-14 | Rome III | Rome III | 4 | 15.9 (11.9-19.9) | 0 (0.0-0.0) |
Self-reported QPGS-RIII | ||||||||
Parental standard questionnaire | ||||||||
Rajindrajith et al[39], 2013, Sri Lanka | Cross-sectional, school-based | 1855 (96.7) | 13-18 | Rome III | Self-reported QPGS-RIII | 5 | 7.7 | |
Self-reported PedsQL4.0 | ||||||||
Sagawa et al[16], 2012, Japan | Cross-sectional, school-based | 3976 (NR) | 10-17 | Rome III | Rome III | 6 | 0.3 | 0.2 |
Self-reported QPGS-RIII | ||||||||
Self-reported PedsQL4.0 | ||||||||
Clinical evaluation | ||||||||
Saps et al[26], 2014, Colombia | Cross-sectional, school-based | 488 (83.2) | 10.0 (mean age) | Rome III | Self-reported QPGS-RIII | 4 | 14.0 (12.0-19.3) | 1.5 (0.7-3.6) |
Parental standard questionnaire | ||||||||
Uc et al[22], 2006, United States | Cross-sectional, primary care | 243 (100) | 4-17 | Rome II | Parental QPGS | 4 | 16.1 | 0.4 |
Clinical evaluation | ||||||||
Zablah et al[27], 2015, El Salvador | Cross-sectional, school-based | 434 (NR) | 8-15 | Rome III | Self-reported QPGS-RIII | 3 | 10.0 | 0.0 |
Parental standard questionnaire | ||||||||
Zhou et al[38], 2011, China | Cross-sectional, school-based | 3671 (NR) | 12-18 | Rome III | Self-reported standard questionnaire | 5 | 24.9 (23.5-26.3) |
- Citation: Boronat AC, Ferreira-Maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in children and adolescents: A systematic review. World J Gastroenterol 2017; 23(21): 3915-3927
- URL: https://www.wjgnet.com/1007-9327/full/v23/i21/3915.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i21.3915